Tag: physical sciences
-
Rapid DNA, RNA Capture Technique Devised
Researchers in Australia developed a simple and inexpensive dipstick technique that captures and purifies specimen samples for genetic analysis in about 30 seconds.
-
Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal
Bayer AG, the global drug maker and agricultural chemical company, is partnering with a Japanese biologics enterprise to discover a series of peptides for therapies.
-
Process Devised for Continuous Stem Cell Production
Researchers in the U.K. developed a process for closed-loop continuous production and collection of large quantities of stem cells for therapies.
-
Thin, Flexible, Lower-Cost Motion Sensors Developed
Engineers in the U.S. and France created and tested motion-detecting sensors more flexible and thinner than today’s sensors, and made with a low-cost process.
-
Report: Health System Not Ready for Alzheimer’s Therapies
A new study finds the U.S. health care system does not have the capacity for large-scale screening and treatment of people with early indicators of Alzheimer’s disease.
-
FDA Clears First Sensor-Pill and App System
The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence.
-
Zymeworks, Janssen in $1.45B Antibody Licensing Deal
Janssen Biotech, a division of drug maker Johnson & Johnson, is acquiring technologies that make it possible to create synthetic antibodies that hit multiple targets.
-
Math Models to Predict Animal-Borne Disease Outbreaks
A team of ecologists and mathematicians is applying machine learning and statistical models to forecast outbreaks of zoonotic diseases, those spread to humans from animals.
-
Cancer Center, Analytics Company Partner on Precision Care
Memorial Sloan Kettering Cancer Center in New York is collaborating with health care analytics company Cota Inc. to offer more precise care strategies for patients.
-
New Drug Shown to Reduce Depressive Behaviors
A new type of treatment for depression that works differently from most other anti-depressive drugs was shown in lab mice to reduce depression-like behaviors.